Sano D - Search Results

1

Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis.

Strati P, Cheng PTM, Steiner RE, Alcedo Andrade PE, Feng L, Sano D, Rao VA, Singh P, Miranda R, Gunther JR, Pinnix CC, Dabaja BS, Cuglievan B, Xing K, Villa D, Skinnider B, Sehn LH, Connors JM, Nieto Y, Ahmed S, Lee HJ, Savage KJ. Strati P, et al. Among authors: sano d. Br J Haematol. 2021 Feb;192(3):560-567. doi: 10.1111/bjh.17281. Br J Haematol. 2021. PMID: 33517581

2

Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis.

Sano D, Liu N, Knowles S, MacEwan JP, Wang S, Wogen J, Yu KS, Lee ST. Sano D, et al. Curr Oncol. 2024 May 2;31(5):2598-2609. doi: 10.3390/curroncol31050195. Curr Oncol. 2024. PMID: 38785476 Free PMC article.

3

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia.

Wang Y, Gali VL, Xu-Monette ZY, Sano D, Thomas SK, Weber DM, Zhu F, Fang X, Deng M, Zhang M, Hagemeister FB, Li Y, Orlowski RZ, Lee HC, Young KH. Wang Y, et al. Among authors: sano d. Neoplasia. 2021 Apr;23(4):361-374. doi: 10.1016/j.neo.2021.02.002. Epub 2021 Mar 15. Neoplasia. 2021. PMID: 33735664 Free PMC article.

4

Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy.

Al Sbihi A, Manasrah N, Sano D, Lonardo S. Al Sbihi A, et al. Among authors: sano d. BMJ Case Rep. 2021 Apr 20;14(4):e240925. doi: 10.1136/bcr-2020-240925. BMJ Case Rep. 2021. PMID: 33879463 Free PMC article.

5

Can Lenalidomide Protect against Severe COVID-19 Symptoms in Multiple Myeloma Patients? A Case Series and Review of the Literature.

Al Sbihi A, Manasrah N, Sano D. Al Sbihi A, et al. Among authors: sano d. Eur J Case Rep Intern Med. 2022 Mar 9;9(3):003216. doi: 10.12890/2022_003216. eCollection 2022. Eur J Case Rep Intern Med. 2022. PMID: 35402321 Free PMC article.

6

Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy.

Al-Katib AM, Gaith H, Sano D, Al-Katib S, Bonnett M, Kafri Z. Al-Katib AM, et al. Among authors: sano d. Clin Case Rep. 2020 Jul 15;8(9):1797-1801. doi: 10.1002/ccr3.3019. eCollection 2020 Sep. Clin Case Rep. 2020. PMID: 32983498 Free PMC article.

7

Nivolumab induced myxedema crisis.

Khan U, Rizvi H, Sano D, Chiu J, Hadid T. Khan U, et al. Among authors: sano d. J Immunother Cancer. 2017 Feb 21;5:13. doi: 10.1186/s40425-017-0213-x. eCollection 2017. J Immunother Cancer. 2017. PMID: 28239466 Free PMC article.

8

Composite Lymphoma: Opposite Ends of Spectrum Meet.

Khan U, Hadid T, Ibrar W, Sano D, Al-Katib A. Khan U, et al. Among authors: sano d. J Clin Med Res. 2017 Mar;9(3):213-215. doi: 10.14740/jocmr2929w. Epub 2017 Jan 25. J Clin Med Res. 2017. PMID: 28179969 Free PMC article.

9

Two primary cancers appeared after discontinuation of nivolumab in the course of treating Hodgkin lymphoma: a case report.

Potluri LB, Nanjareddy S, Al Sbihi A, Manasrah N, Smith W 4th, Sano D. Potluri LB, et al. Among authors: sano d. AME Case Rep. 2023 Jul 10;7:30. doi: 10.21037/acr-22-87. eCollection 2023. AME Case Rep. 2023. PMID: 37492791 Free PMC article.

10

Platelets and renal failure in the SARS-CoV-2 syndrome.

Taha M, Sano D, Hanoudi S, Esber Z, Elahi M, Gabali A, Chopra T, Draghici S, Samavati L. Taha M, et al. Among authors: sano d. Platelets. 2021 Jan 2;32(1):130-137. doi: 10.1080/09537104.2020.1817361. Epub 2020 Sep 6. Platelets. 2021. PMID: 32892687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters